$89.6 Thousand is the total value of Amica Retiree Medical Trust's 99 reported holdings in Q2 2023. The portfolio turnover from Q1 2023 to Q2 2023 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| NI | Exit | NISOURCE INC | $0 | – | -5,544 | -100.0% | -0.16% | – |
| ROP | Exit | ROPER TECHNOLOGIES INC | $0 | – | -443 | -100.0% | -0.21% | – |
| ROK | Exit | ROCKWELL AUTOMATION INC | $0 | – | -1,277 | -100.0% | -0.40% | – |
| BR | Exit | BROADRIDGE FINANCIAL SOLUTIO | $0 | – | -2,885 | -100.0% | -0.45% | – |
| XLE | Exit | ENERGY SELECT SECTOR SPDR FUNDenergy | $0 | – | -5,401 | -100.0% | -0.47% | – |
| XLI | Exit | INDUSTRIAL SELECT SECTOR SPDRsbi int-inds | $0 | – | -5,286 | -100.0% | -0.57% | – |
| BLL | Exit | BALL CORP | $0 | – | -14,934 | -100.0% | -0.87% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-08-07
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| APPLE INC | 40 | Q3 2023 | 6.5% |
| MICROSOFT CORP | 40 | Q3 2023 | 7.1% |
| JPMORGAN CHASE & CO | 40 | Q3 2023 | 2.8% |
| JOHNSON & JOHNSON | 40 | Q3 2023 | 2.0% |
| PROCTER & GAMBLE CO | 40 | Q3 2023 | 1.9% |
| VISA INC CLASS A SHARES | 40 | Q3 2023 | 1.9% |
| HOME DEPOT INC | 40 | Q3 2023 | 1.5% |
| MASTERCARD INCORPORATED | 40 | Q3 2023 | 1.9% |
| CHEVRON CORPORATION | 40 | Q3 2023 | 1.6% |
| ABBOTT LABS | 40 | Q3 2023 | 1.7% |
View Amica Retiree Medical Trust's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2023-11-03 |
| 13F-HR | 2023-08-07 |
| 13F-HR | 2023-05-05 |
| 13F-HR | 2023-02-08 |
| 13F-HR | 2022-10-24 |
| 13F-HR | 2022-07-29 |
| 13F-HR | 2022-05-11 |
| 13F-HR | 2022-02-08 |
| 13F-HR | 2021-11-03 |
| 13F-HR | 2021-08-04 |
View Amica Retiree Medical Trust's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.